Database updated: 27 October 2026
Safety Information
Medsafe Online Recall Database
Detail of Recall
| Type of Product: | Medicine |
| Medsafe Reference: | 24591 |
| Brand Name: | Curam |
| Dose Form/Strength: | Powder for oral suspension 250mg, 62.5mg/5mL |
| Affected: | HX3976 & HX9731 |
| Recalling Organisation: | Novartis New Zealand Ltd Private Office 3.15 12 Madden Street Wynyard Quarter Auckland 1010 |
| Contact Information: | |
| Manufacturer: | Sandoz GmbH |
| Issue: | Potential defect during manufacturing relating to a failure of the sealing system of the bottle that may lead to ingress of moisture resulting in a degradation of Clavulanic acid |
| Recall action type: | Recall |
| Recall action: | Recall |
| Level of recall: | Hospital/Pharmacy/Laboratory |
| Date Commenced: | 20/5/2019 |
